CYTOCARE 502 - 516 - 532 - HAIRCARE | FRANCE HEALTH

CYTOCARE - REVITACARE

REVITACARE is a French laboratory, founded in 2003, specialized in research design and manufacture of implants and products dedicated to cosmetology and aesthetic medicine used in the prevention and correction of the skin aging effects, and the treatment of hair problems.
REVITACARE’ s medical devices comply with the essential requirements of the Council Directive 93/42/EEC and its amendments concerning medical devices.
QUALITY. SECURITY. EFFICIENCY.
Class III Medical Devices. HA Quality: Biotechnological origin, non-crosslinked. Biocompatible in compliance with ISO 10993 international standards: non-cytotoxic, non-irritant, non sensitizing, non-mutagenic, non-genotoxic. Microbiological safety.

PROFESSIONAL RANGE. USE IN MEDICAL CABINET AS NEED FOR A MEDICAL ACT CARRIED OUT BY A SPECIALIZED DOCTOR, DERMATOLOGIST OR AESTHETIC MEDICINE.

All CYTOCARE by REVITACARE are on France-health, the on-line parapharmacy specialized in aesthetic medicine, mesotherapy and care: all dermal filler brands, hyaluronic acid injections, cosmetic facial filler, medical devices, pre and post injections, cannulas, thread lift, accessory, beauty care and anti-aging products.

CYTOCARE S Line (1x3ml) REVITACARE
€120.00 (tax excl.)
(tax excl.)
CYTOCARE S Line  improves the skin quality with advanced skin aging: filling in fine lines, restoring radiance. Injectable by microinjections into the superficial dermis and mid-dermis of peri-orbital and perioral fine lines such as vertical lip lines. Non-crosslinked hyaluronic acid 18 mg + Rejuvenating complex. For women and men, for advanced skin type.
CYTOCARE 516 (10x5ml) REVITACARE
€209.00 (tax excl.)
(tax excl.)
CYTOCARE 516 is a healthy complexion, a significant increase in turgor and hydration of the skin, reduction of appearance of wrinkles. Formula combined CT50 rejuvenating complex and hyaluronic acid 16mg. CORRECTION. CYTOCARE 516 reduces wrinkles and fine lines. High hydration. Antioxidant and protective effects.